Profile
Melan Group is a comprehensive enterprise group engaged in the research and development, production, sales and service of animal biological products and drugs. It has 6 subsidiaries, three pharmaceutical industrial parks and a research and development institution, covering a total area of more than 500 mu. It has 48 new GMP production lines, and its products cover more than 300 kinds of products in four major sectors: veterinary drug preparations, veterinary biological products, traditional Chinese medicine extraction and pet medicine.
At present, the group has 7 high-tech enterprises, 2 provincial "specialized and special new" enterprises, and 12 national and provincial innovation platforms such as national enterprise technology center, provincial key laboratory, provincial engineering technology research center and post doctoral innovation practice base. It has successively undertaken 12 national, provincial and ministerial-level science and technology plan projects such as national key research and development plans, local science and technology projects introduced by the central government, and provincial major science and technology projects. 154 national patents were authorized, 7 national new veterinary drug certificates, 7 clinical approvals, 1 first prize of national agriculture, animal husbandry and fishery harvest award, 1 excellent award of national innovation and entrepreneurship competition, 1 second prize of provincial innovation and entrepreneurship competition, and 87 provincial scientific and technological achievements. The research and development of animal polyvalent vaccine is in the forefront of the industry, in the cell suspension culture and other veterinary vaccine manufacturing to reach a higher level of domestic. The company has rich product categories and strong service guarantee capabilities. It has sales and service centers in various provinces and cities in China and countries along the "Belt and Road". The quality and sales of products such as poultry multi-linked multivalent vaccines, Chinese medicine oral liquids, additives, and high-tech preparations Both rank among the top in the country.
Industrial Layout
Melan Group Pharmaceutical Industrial Park
Located in Shangqiu Zhecheng Industrial Zone, it covers an area of more than 150 acres with a total investment of 510 million yuan. At present, the park has a majestic automated office building and a high-standard modernized plant group. The park has superb animal drug production lines in the industry, built with powder premixing workshop, dispersant workshop, traditional Chinese medicine extraction workshop, aqueous injection workshop, oral liquid workshop, disinfectant workshop and so on, which can meet the customer's demand for various dosage forms. The quality inspection department is equipped with various high-precision laboratory equipment, such as high-performance liquid chromatograph, ultraviolet analyzer and aseptic laboratory, to ensure product quality monitoring in the production process. The company has been awarded the Henan Province Slow and Controlled Release Veterinary Pharmaceutical Preparation Engineering and Technology Research Center, Henan Province Engineering Laboratory of New Veterinary Traditional Chinese Medicine Preparation, Henan Province Veterinary Pharmaceutical Preparation Engineering and Technology Research Center, etc.
Melan Group Vaccine Industrial Park
Founded in 2013, with a total investment of 1 billion yuan, the first phase of the project invested 350 million yuan, covers an area of more than 120 acres, is located in the High-tech Development Zone in Zhecheng County. The park is equipped with veterinary biological products production workshop, quality inspection center, laboratory animal house and office building. The R&D center under the company has been awarded as Henan Provincial Pathogenic Microorganisms Genetic Engineering Research Center, Henan Provincial Key Laboratory, National Enterprise Technology Center, Post-doctoral Scientific Research Station, and Henan Provincial New Type R&D Institution.
While insisting on independent research and development, the company has established long-term cooperative relationships with the Institute of Microbiology of the Chinese Academy of Sciences, Nanjing Agricultural University, Chinese Academy of Agricultural Sciences, Henan Agricultural University and other well-known institutions in the field of “genetic engineering vaccine”, “traditional Chinese medicine adjuvant” and other aspects, and has formed an industry-academia-research consortium to promote the development of microorganisms. Formation of industry-academia-research consortium for the company's product development and innovation to provide a solid technical backing for the long-term rapid development of the enterprise has laid a solid foundation.
Melan Group Biotechnology Industrial Park
Located in Zhecheng County Industrial Cluster East Danyang Avenue North, with a total investment of 1.06 billion yuan, covers an area of about 260 acres, with a total construction area of 80,000 square meters, belonging to the new project, the construction of office buildings, standardized plant, R & D center, warehousing and 12 fully automated intelligent veterinary drug production line. At present, the third phase of the pharmaceutical industrial park construction of the new version of the veterinary drug GMP production line has passed the acceptance of the Ministry of Agriculture, Henan Province, the priority through the new version of the veterinary drug GMP enterprises.
Melan Group Microecological Preparations and Traditional Chinese Medicine Extraction Industrial Park
Located in Zhecheng County Industrial Cluster, the industrial park covers an area of about 300 acres. After the completion of the park, it will form a diversified and comprehensive industrial park integrating the production of micro-ecological preparations, the extraction of traditional Chinese medicine as well as medicines for pets.
Six Five-Year Plans
2009-2013
The First Five-Year Plan
Meilan Group has built a veterinary drug GMP workshop with the largest scale and the most complete dosage forms in China. The dosage forms cover powder, powder, premix, traditional Chinese medicine extraction, oral solution, injection, powder injection, disinfectant, granule and tablet, with an annual turnover of 0.1 billion.
2014-2018
The Second Five-Year Plan
Meilan Group is involved in the field of veterinary products. Establish a veterinary biological products production plant with the highest scientific and technological content and the most complete dosage form in China, with an annual turnover of more than 1 billion.
2019-2023
The Third Five-Year Plan
Meilan Group will enter the capital market to operate and go public. By then, Meilan Group's employees will have more than 10 multimillionaires and more than 100 millionaires, allowing all employees to have an annual income of more than 100000. Meilan Group will have annual sales of 1.5 billion yuan and enter the capital market for listing.
2024-2028
The Fourth Five-Year Plan
Realize and consolidate the strategic goal of listing on the main board of the group company, and the sales volume reached 1 billion.
2029-2033
The Fifth Five-Year Plan
Establish and improve the group's multi-industry chain and multi-sector development pattern. The industry involves high-end veterinary drug preparations, veterinary biological products, pet drugs, pet food, microbial fermentation, Chinese medicine extraction and other sectors, with annual sales reaching 2 billion.
2034-2038
The Sixth Five-Year Plan
After six five-year plans and 30 years of development, we have achieved a platform for 3000 partners to create, share and enrich together, and the annual sales have reached 3 billion market sales!
Address:
No. 9 Zhuzhou Road, High tech Development Zone, Zhecheng County, Shangqiu City, Henan Province
Message
Leave comments and suggestions here and we will reply to you in time.
